arginine vasotocin [963]
arginine vasotocin
| SMILES | CC[C@H](C)C1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCCC2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O |
| InChIKey | OXDZADMCOWPSOC-ICBIOJHSSA-N |
| Sequence | CYIQNCPRG |
| HELM | PEPTIDE1{C.Y.[*C(=O)C([C@@H](C)CC)N* |$_R2;;;;;;;;;_R1$|].Q.N.C.(P,[dP]).R.G.[am]}$PEPTIDE1,PEPTIDE1,1:R3-6:R3$$$V2.0 |
Chemical Properties
| Hydrogen bond acceptors | 16 |
| Hydrogen bond donors | 14 |
| Rotatable bonds | 19 |
| Log P | -5.601 |
| Molecular weight (Da) | 1049.5 |
| Stereochemistry info | partial |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
arginine vasotocin
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0